Trending...
- Elder Abuse Case Against Healthy Traditions Owner Raises Questions As To The Dire Reality Of Abuse Against The Last Of The Baby Boomers
- Pure Energy Electrical Services, LLC Announces Strong Start to 2026, Reinforcing Customer-First Electrical Service Across Northeast Florida
- Notice: Hrm Queen Laurence I Assumes Crown Control & $317q Fund. 3bn Unopoly Shares Settled. Requisition Of Buckingham Palace & Windsor Castle Final
Through a new partnership, Acmeware will provide a FHIR-enabled integration layer that allows Avo to access MEDITECH clinical data in real time at the point of care.
MEDFIELD, Mass. - ncarol.com -- Acmeware, a MEDITECH Alliance Partner, announced a partnership with Avo (AvoMD), an AI platform for clinical copilots and a fellow MEDITECH Alliance Partner. Together, the organizations are enabling MEDITECH customers to seamlessly push and pull data between MEDITECH and Avo's AI-powered clinical tools. As part of this partnership, Acmeware will serve as a seamless data integration layer for Avo's AI suite within MEDITECH environments, delivering a standards-based API using the HL7® FHIR® data format.
Through Acmeware's FHIR-enabled API, Avo can securely access real-time clinical data from MEDITECH to power context-aware, evidence-based decision support at the point of care. The integration is designed to align with MEDITECH architecture and interoperability frameworks while minimizing implementation complexity for provider organizations with one simple install.
Early adopters of the Acmeware–Avo integration include Moab Regional Hospital, Emanate Health, and Holyoke Medical Center, all of which are leveraging the solution to streamline access to AI-generated insights and documentation directly within their MEDITECH systems.
AI capabilities that will be further enhanced with this real-time integration include: Avo's Chart Assist functionality for workflows like pre-charting, admissions, and discharge, Ask Avo, a smart EHR-search and AI consult with patient data awareness, and AI Scribe, with longitudinal patient context awareness and automatic note-pushing.
More on ncarol.com
"This partnership reflects our focus on delivering production-grade interoperability using modern standards," said Joel Benware, President and CEO of Acmeware. "By exposing MEDITECH data through a robust FHIR-based API, we're giving healthcare organizations flexible, scalable options to connect Avo's AI-driven insights directly to MEDITECH."
The collaboration expands upon Avo's existing relationship with MEDITECH through its Alliance partnership, while offering customers additional integration paths powered by Acmeware's interoperability expertise. Acmeware's integration layer ensures reliable access to the required clinical context—including patient, encounter, and observation data—while maintaining performance, security, and compliance requirements.
"At Avo, we've partnered with over 30 MEDITECH customers to support clinical workflows with the latest and greatest in AI at the point of care," said Joongheum Park, MD, Chief Product & AI Officer at Avo. "Working with Acmeware allows us to extend the value of our AI tools within MEDITECH environments in ways that fit naturally into provider workflows."
The partnership supports healthcare organizations seeking to extend MEDITECH with external clinical decision support capabilities while adhering to interoperability best practices. Together, Acmeware and Avo aim to simplify integration, reduce maintenance overhead, and support clinically meaningful use of real-time data.
Why it matters
As healthcare organizations increasingly look to extend EHR functionality using third-party applications, standards-based integration has become critical. This partnership highlights how FHIR APIs can be used to deliver real-time clinical decision support in MEDITECH environments.
More on ncarol.com
For more information about Acmeware, visit www.acmeware.com.
For more information about AvoMD, visit www.avomd.com.
2 / 2
About Acmeware
Acmeware, Inc. provides data integration, professional services, training, solutions, and custom software that assist clients in realizing the maximum benefit from their MEDITECH EHR. We are a service-oriented company working in partnership with our clients to leverage the latest technologies, transform disparate raw data to knowledge, and deliver valuable insight to healthcare organizations. Acmeware's dedicated focus on MEDITECH related services allows us to provide solutions that are innovative, efficient, accurate, and affordable. acmeware.com
About Avo
Avo is the future-proof AI platform used by healthcare organizations to improve care and operational outcomes in a way clinicians love. Avo's platform offers end-to-end EHR copilots that simplify everyday clinical tasks like documentation, charting, discharge planning, ordering and more. Avo supports every member of the care team by effortlessly incorporating guidelines, protocols, and patient data into the workflow and transforming them into actionable tools. At Avo, we believe in standardizing care with love, not alerts. Visit avomd.com to learn more.
Through Acmeware's FHIR-enabled API, Avo can securely access real-time clinical data from MEDITECH to power context-aware, evidence-based decision support at the point of care. The integration is designed to align with MEDITECH architecture and interoperability frameworks while minimizing implementation complexity for provider organizations with one simple install.
Early adopters of the Acmeware–Avo integration include Moab Regional Hospital, Emanate Health, and Holyoke Medical Center, all of which are leveraging the solution to streamline access to AI-generated insights and documentation directly within their MEDITECH systems.
AI capabilities that will be further enhanced with this real-time integration include: Avo's Chart Assist functionality for workflows like pre-charting, admissions, and discharge, Ask Avo, a smart EHR-search and AI consult with patient data awareness, and AI Scribe, with longitudinal patient context awareness and automatic note-pushing.
More on ncarol.com
- US Interest Rate Pivot: Hedge Funds Leverage Tickeron AI for 177% Annualized Return
- Pastor Saeed Abedini Releases THE TRUTH – Volume 1, A Deeply Personal Story of Faith, Struggle, and Redemption
- New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
- Craigory Dunn & Dre Barracks Release Gospel-Soul Collaboration The Soul Renaissance
- Why Screen-Fatigued Parents are Choosing the Human Bridge
"This partnership reflects our focus on delivering production-grade interoperability using modern standards," said Joel Benware, President and CEO of Acmeware. "By exposing MEDITECH data through a robust FHIR-based API, we're giving healthcare organizations flexible, scalable options to connect Avo's AI-driven insights directly to MEDITECH."
The collaboration expands upon Avo's existing relationship with MEDITECH through its Alliance partnership, while offering customers additional integration paths powered by Acmeware's interoperability expertise. Acmeware's integration layer ensures reliable access to the required clinical context—including patient, encounter, and observation data—while maintaining performance, security, and compliance requirements.
"At Avo, we've partnered with over 30 MEDITECH customers to support clinical workflows with the latest and greatest in AI at the point of care," said Joongheum Park, MD, Chief Product & AI Officer at Avo. "Working with Acmeware allows us to extend the value of our AI tools within MEDITECH environments in ways that fit naturally into provider workflows."
The partnership supports healthcare organizations seeking to extend MEDITECH with external clinical decision support capabilities while adhering to interoperability best practices. Together, Acmeware and Avo aim to simplify integration, reduce maintenance overhead, and support clinically meaningful use of real-time data.
Why it matters
As healthcare organizations increasingly look to extend EHR functionality using third-party applications, standards-based integration has become critical. This partnership highlights how FHIR APIs can be used to deliver real-time clinical decision support in MEDITECH environments.
More on ncarol.com
- Scotch Whisky Market Dislocation Creates Compelling Entry Opportunity for Long-Term Investors
- Peccioli Becomes New Orleans: In July 2026, the magic of jazz comes to Tuscany
- Luxur Tequila Introduces a New Standard of Luxury Spirits with Customizable Bottles & Visionary Lea
- Pepper Moon Catering Awarded Five-Year Single-Award BPA with NC Army National Guard (NC-ARNG)
- Local Eco-Friendly Cleaning Company Expands Services to Cary, Apex, and Morrisville
For more information about Acmeware, visit www.acmeware.com.
For more information about AvoMD, visit www.avomd.com.
2 / 2
About Acmeware
Acmeware, Inc. provides data integration, professional services, training, solutions, and custom software that assist clients in realizing the maximum benefit from their MEDITECH EHR. We are a service-oriented company working in partnership with our clients to leverage the latest technologies, transform disparate raw data to knowledge, and deliver valuable insight to healthcare organizations. Acmeware's dedicated focus on MEDITECH related services allows us to provide solutions that are innovative, efficient, accurate, and affordable. acmeware.com
About Avo
Avo is the future-proof AI platform used by healthcare organizations to improve care and operational outcomes in a way clinicians love. Avo's platform offers end-to-end EHR copilots that simplify everyday clinical tasks like documentation, charting, discharge planning, ordering and more. Avo supports every member of the care team by effortlessly incorporating guidelines, protocols, and patient data into the workflow and transforming them into actionable tools. At Avo, we believe in standardizing care with love, not alerts. Visit avomd.com to learn more.
Media Contact
Greg D'Abate, VP of Sales & Marketing, Acmeware
Shelly Sasson, VP of Marketing & Strategy, Avo
gldabate@acmeware.com
Greg D'Abate, VP of Sales & Marketing, Acmeware
Shelly Sasson, VP of Marketing & Strategy, Avo
gldabate@acmeware.com
Source: Acmeware, Inc
0 Comments
Latest on ncarol.com
- CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs
- NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
- Revenue Optics Launches Talent Infrastructure Platform for SaaS Revenue Hiring and Appoints Sabz Kaur to Lead Growth
- Building a Multi-Domain Autonomous Systems Platform at the Intersection of AI, Defense and Infrastructure: VisionWave Holdings (N A S D A Q: VWAV)
- Bent Danholm Named "Top Luxury Real Estate Leader" in Modern Luxury Miami
- Author Ken Mora to Celebrate New Caravaggio Book Debut with Special Event at Palazzo Venezia Naples
- Matthew Sisneros Releases Raw and Unfiltered Memoir: The Devil Lost Another One — A Powerful Story of Crime, Consequence, and Redemption
- From Life to Light: Jess L. Martinez Shares a Soulful Poetry Collection That Explores What It Means to Be Human
- Lawsuit Filed Against Boeing Over Defective Seat Switch on Boeing 787
- Quadcode Acquires Significant Stake in Game 7, LLC - The Parent Company for FPFX Tech and PropAccount.com
- Danholm Collection Announces Sale of 16689 Broadwater Ave in Winter Garden, Highlighting Strong Performance in Twinwaters Community
- Cleveland County Families Choosing to Restore Quality Furniture Instead of Buying New
- Strong Clinical Results for Breakthrough Liver Diagnostic Platform; ENDRA Life Sciences (N A S D A Q: NDRA) $NDRA
- 46th International Symposium On Forecasting – Dates, Venue And Speakers Announced
- Phoenix Rebellion Therapy Celebrates 10 Years Helping Utahns Overcome Trauma as Utah Faces Nation's 2nd-Highest Rate of Mental Health Challenges
- Bonavita Luxury & Portable Lavatories Announces Rebrand to Bonavita Site Solutions
- Raleigh Emerges as a Key Player in Sustainable Fashion Innovation for 2026
- Notice: Hrm Queen Laurence I Assumes Crown Control & $317q Fund. 3bn Unopoly Shares Settled. Requisition Of Buckingham Palace & Windsor Castle Final
- 13 Full Moons of Black Dandelion Convergent Voice™ An Integration of Literacy & Wellness Symposium
- Emperor of the Cherokee: A Novel Debuts
